Selected studies within the last 10 years exploring the prognostic significance of VEGF and associated factors in breast cancers using immunohistochemistry methodology are highlighted in Table 1, considering immunohistochemistry as a part of routine histopathological examination. The gene discussed is VEGFA; the disease is breast carcinoma.